AI-Supported Mammography Screening Shows Promising Results in Swedish Trial
A groundbreaking interim safety analysis of the first randomized trial investigating the use of artificial intelligence (AI) in a national breast cancer screening program has revealed encouraging results. The trial, conducted in Sweden with over 80,000 women, demonstrated that AI-supported screening detected 20% more cancers compared to routine double reading of mammograms by two breast…